Perspective Therapeutics (CATX) Revenue & Revenue Breakdown


OverviewForecastFinancialsChart

Perspective Therapeutics Revenue Highlights


Latest Revenue (Y)

$1.43M

0

Perspective Therapeutics Revenue by Period


Perspective Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$1.43M-79.81%
2022-12-31$7.10M-34.19%
2022-06-30$10.79M7.38%
2021-06-30$10.05M3.85%
2020-06-30$9.68M32.35%
2019-06-30$7.31M23.48%
2018-06-30$5.92M24.41%
2017-06-30$4.76M-0.17%
2016-06-30$4.77M3.53%
2015-06-30$4.61M9.18%
2014-06-30$4.22M-6.76%
2013-06-30$4.53M-10.76%
2012-06-30$5.07M-3.20%
2011-06-30$5.24M-0.89%
2010-06-30$5.29M-2.43%
2009-06-30$5.42M-24.32%
2008-06-30$7.16M24.76%
2007-06-30$5.74M187.72%
2006-06-30$1.99M888.60%
2005-06-30$201.73K100.00%
2004-09-30-100.00%
2003-09-30-100.00%
2002-09-30-100.00%
2001-09-30-100.00%
2000-09-30-100.00%
1999-09-30-100.00%
1998-09-30--100.00%
1997-09-30$7.85M-4.96%
1996-09-30$8.26M5.64%
1995-09-30$7.82M15.16%
1994-09-30$6.79M-

Perspective Therapeutics generated $1.43M in revenue during NA 2023, up -79.81% compared to the previous quarter, and up 19.61% compared to the same period a year ago.

Perspective Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30--100.00%
2025-03-31$342.00K100.00%
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$337.00K-82.35%
2023-09-30$1.91M27.27%
2023-06-30$1.50M-18.03%
2023-03-31$1.83M-0.27%
2022-12-31$1.83M6.87%
2022-09-30$1.72M-31.46%
2022-06-30$2.50M-13.92%
2022-03-31$2.91M3.34%
2021-12-31$2.82M9.83%
2021-09-30$2.56M-5.39%
2021-06-30$2.71M4.23%
2021-03-31$2.60M10.22%
2020-12-31$2.36M-1.05%
2020-09-30$2.38M4.61%
2020-06-30$2.28M-20.87%
2020-03-31$2.88M30.55%
2019-12-31$2.21M-4.71%
2019-09-30$2.31M20.32%
2019-06-30$1.92M-
2019-03-31$1.92M1.05%
2018-12-31$1.90M21.90%
2018-09-30$1.56M-2.56%
2018-06-30$1.60M1.91%
2018-03-31$1.57M2.41%
2017-12-31$1.54M26.84%
2017-09-30$1.21M-11.61%
2017-06-30$1.37M6.86%
2017-03-31$1.28M24.71%
2016-12-31$1.03M-4.90%
2016-09-30$1.08M-3.50%
2016-06-30$1.12M-6.55%
2016-03-31$1.20M12.49%
2014-12-31$1.07M2.25%
2014-09-30$1.04M9.75%
2014-06-30$949.52K-16.29%
2014-03-31$1.13M4.51%
2013-12-31$1.09M3.38%
2013-09-30$1.05M-15.47%
2013-06-30$1.24M-0.75%
2013-03-31$1.25M28.30%
2012-12-31$975.46K-7.65%
2012-09-30$1.06M-19.47%
2012-06-30$1.31M-0.43%
2012-03-31$1.32M7.22%
2011-12-31$1.23M1.26%
2011-09-30$1.21M-3.41%
2011-06-30$1.26M-10.95%
2011-03-31$1.41M13.32%
2010-12-31$1.24M-6.19%
2010-09-30$1.33M-0.62%
2010-06-30$1.34M10.99%
2010-03-31$1.20M-12.07%
2009-12-31$1.37M-0.78%
2009-09-30$1.38M14.42%
2009-06-30$1.21M-11.79%
2009-03-31$1.37M2.98%
2008-12-31$1.33M-12.69%
2008-09-30$1.52M-

Perspective Therapeutics generated - in revenue during Q2 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Perspective Therapeutics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
LUCDLucid Diagnostics$4.35B$1.16B
TOROToro$84.83M$7.60M
LUNGPulmonx$83.79M$23.86M
NPCENeuroPace$79.91M$23.52M
LGMKLogicMark$9.93M$2.59M
CATXPerspective Therapeutics$1.43M-
ZVSAZyVersa Therapeutics--
UNCYUnicycive Therapeutics--

CATX Revenue FAQ


What is Perspective Therapeutics’s yearly revenue?

Perspective Therapeutics's yearly revenue for 2023 was $1.43M, representing a decrease of -79.81% compared to 2022. The company's yearly revenue for 2022 was $7.1M, representing a decrease of -34.19% compared to 2021. CATX's yearly revenue for 2021 was $10.8M, representing an increase of 7.38% compared to 2020.

What is Perspective Therapeutics’s quarterly revenue?

Perspective Therapeutics's quarterly revenue for Q2 2025 was $0, a -100.00% decrease from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $342K, a 100.00% increase from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). CATX's quarterly revenue for Q4 2024 was $0, a 100.00% increase from the previous quarter (Q3 2024), and a -100.00% decrease year-over-year (Q4 2023).

What is Perspective Therapeutics’s revenue growth rate?

Perspective Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -86.72%, and for the last 5 years (2019-2023) was -85.19%.